Collectively, these studies suggest that the PKD1 and
The results of animal studies also support a "two-hit" morbid consequences. Given the lack of an effective model of cyst formation. Mice heterozygous for targeted therapy, much attention has been focused on defining mutations of either Pkd1 or Pkd2 have few cysts while the pathogenesis of cyst formation.
homozygous animals die in utero with severe cystic disSeveral lines of evidence suggest that dysregulation ease (Lu et al., 1997 (Lu et al., , 2001 ; Wu et al., 1998). of epithelial cell growth is a key step in this process.
The observation that animals with homozygous mutaThe cysts are fluid-filled structures lined by epithelial tions of either Pkd1 or Pkd2 die in utero in the later cells that are both hyperproliferative and hyperapoptotic stages of gestation suggests that both gene products (Lanoix et al., 1996; Woo, 1995) . Micropolyps are freare essential for normal development. The two models quently observed projecting into the lumen, but oncohave similar patterns of renal development, with grossly genic transformation is very uncommon (Torres, 1990) , normal patterns of ureteric bud branching and mesenpossibly due to the increased apoptosis that accompanchymal induction. Abruptly, around E15, cystic strucies the increased rate of growth. The cystic epithelium tures arise in the center of the organ, in the portion that has a high mitotic rate in vivo as measured by PCNA is most developmentally advanced. It is postulated that staining (Nadasdy et al., 1995) and increased levels of the polycystin complex is required for the final maturation of renal epithelia. Collectively, these studies suggest that the PKD1 and PKD2 gene products function in a cooperative manner ties are regulated by the relative ratio of cyclins and Cdk inhibitors (CKIs) with which they are associated (Sherr to regulate growth and cellular differentiation. We have recently described a cell culture system that provides and Roberts, 1999). The transition from G0/G1 into S phase, a process that appears to be inhibited by polydirect evidence in support of this hypothesis (Boletta et al.
, 2000). Madin Darby canine kidney cell lines (MDCK)
cystin-1, is specifically regulated by the activities of Cdk2, Cdk4, and Cdk6. Therefore, we first examined with stable overexpression of the full-length cDNA for human PKD1 had a reduced rate of growth, were more whether polycystin-1 exerted its effects by altering the activity of any of these Cdks. As shown in Figure 2A , resistant to apoptosis, and spontaneously formed branching tubules when cultured in three-dimensional the activity of Cdk2 was dramatically inhibited in both the MDCK PKD1/Zeo clones and Hek293 cells with transient collagen gels. In the current study, we describe a pathway by which the polycystin complex mediates some of expression of polycystin-1, but not in MDCK Zeo or in Hek293 cells transfected with R4227X-F or empty vecthese effects and show that the function of this signaling system is altered in Pkd1 null animals.
tor. In contrast, polycystin-1 expression had no effect on the level of activity of either Cdk4 or Cdk6. ) when grown on plastic dishes, an effect dependent manner, one would expect that overexpreseven more pronounced when the clones were cultured sion of PKD1-F in a cell line lacking p21 waf1 should have suspended in collagen matrix (data not shown). As the little effect on its growth rate. We tested this prediction first step in defining the mechanism by which polyby comparing the BrdU incorporation rates of p21 ϩ/ϩ cystin-1 exerts these effects, we tested whether inhibiand p21 Ϫ/Ϫ cells that had been cotransfected with GFP tion of proliferation was cell cycle dependent. Comparand either PKD1-F, R4227X-F, or empty vector. Transing the cell cycle profile of two MDCK PKD1/Zeo clones (C8/ fected cells were sorted based on GFP expression and 68 and G7/36) to that of a MDCK Zeo clone (F6), we found then analyzed for BrdU incorporation and polycystin-1 that 75% and 89% of the C8/68 and G7/36 cells, but expression. We found inhibition of BrdU incorporation only 43% of the F6 cells were accumulated in G0/G1 only in p21 ϩ/ϩ cells that had been transfected with ( Figure 1A ). Figure 2C ), even though PKD1-F and R4227X-F These data suggested that overexpression of human were expressed at equivalent levels (data not shown). polycystin-1 in a heterologous cell line could cause These data suggest that p21 waf1 is necessary in PKD1-growth arrest in G0/G1. Next, we examined the possibilmediated growth inhibition. ity that the effects were due to irrelevant clonal differWe next sought to determine whether the increased ences, a cell-type-specific effect of PKD1 expression, level of p21 waf1 that results from polycystin-1 expression or a nonspecific toxic effect due to forced overexpression of a very large protein. We first created a construct is the result of upregulation of its transcription. To adthat expresses a clinically relevant mutant form of polydress this issue, we tested for increased activation of cystin-1 of nearly identical length (R4227X-F) that has the p21 waf1 promoter using a luciferase reporter assay. a stop codon introduced in the middle of the coiledThe reporter construct WWP-Luc was cotransfected coil motif (Hanaoka et al., 2000; Figure 1C ). We then with PKD1-F, R4227X-F, or empty vector (pCI) into cotransfected a plasmid encoding GFP with either an Hek293 cells and tested for luciferase activity at 24 hr. epitope-tagged form of human wild-type PKD1 (PKD1-F) PKD1-F increased the luciferase activity about 8-fold, or R4427X-F into two different human cell lines (Hek, whereas R4227X-F and pCI had negligible effects ( moters that contained either 13 or 15 tandemly arranged phorylated STAT1 exclusively in C8/68 ( Figure 3B ). Consistent with these results, we detected STAT1 homodicopies of the normal (PG13-Luc) or mutant (MG15) p53 binding site, respectively. In contrast, mutation of the mers by electrophoretic mobility-shift assay (EMSA) in nuclear extracts of C8/68 but not in F6 ( Figure 3C ). These putative STAT1 binding site resulted in a complete loss of luciferase activity. results suggest that STAT1 is constitutively activated in C8/68 but not in control clone MDCK Zeo .
PKD1-F (

Activation of STAT1 in Cells Overexpressing
Polycystin-1 PKD1 Inhibits Growth and Induces p21 waf1 in STAT1 Null Cells after Reconstitution of STAT1 Activity STAT1 is a latent cytoplasmic transcription factor that translocates to the nucleus after activation by phosphorIf STAT1 is responsible for inducing p21 waf1 and cell growth arrest in response to polycystin-1, then polycysylation (Schindler and Darnell, 1995) . Given the results of the p21-promoter assays, we tested for STAT1 activatin-1 should not have these effects when overexpressed in cells lacking STAT1. To test this hypothesis, we coextion by PKD1 using two independent methods. First, we measured the effect of polycystin-1 on the transcrippressed PKD1-F, R4227X-F, or empty vector (pCI) with GFP in STAT Ϫ/Ϫ (U3A) and parental STAT ϩ/ϩ (2ftgh) cells tional activity of endogenous STAT1 in Hek293 using a luciferase reporter assay. We cotransfected empty and selected for transfected cells by FACS. Immunoblot analysis confirmed that equal levels of expression of vector, PKD1-F, or R4227X-F with a reporter construct (Sahni et al., 1999) . Only PKD1-F induced a significant PKD1-F and R4227X-F were achieved ( Figure 4A ). As predicted, PKD1-F specifically induced p21 waf1 in 2ftgh increase (8-fold) of relative luciferase activity under these conditions ( Figure 3A) . Similar results were obcells but not in U3A cells ( Figure 4A ). Coexpression of STAT1 with PKD1-F in the U3A cells, however, resulted tained using Hela cells (data not shown). Next, we tested whether endogenous STAT1 was fully activated in the in the usual upregulation of p21 waf1 ( Figure 4B ). In parallel experiments, neither R4227X-F nor pCI was capable MDCK Zeo/PKD1 (C8/68) clone by testing for phosphorylation of S727 and Y701 using epitope-specific antibodies of inducing p21 waf1 in these reconstitution experiments ( Figure 4B ). Next, we compared the growth effects of ( Figure 3B ). While total STAT1 protein levels were no different between the C8/68 and negative controls (F6), PKD1 expression in the U3A and 2ftgh cells. We coexpressed PKD1-F, R4227X-F, or pCI with GFP in cells of we found increased levels of tyrosyl-and serine-phos- Figure 3E ). Approximately 3-fold higher levels of luciferase activity were consistently observed in the PKD1 ϩ essential for PKD1-mediated growth inhibition in this cell culture system ( Figure 4C ). clones compared to the negative controls. We were, however, unable to detect the tyrosyl-phosphorylated form of activated STAT3 either in MDCK PKD1/Zeo or HepG2 PKD1 Induces STAT3 Activation Using an MDCK tubulogenesis cell culture system simicells transiently expressing PKD1-F. Likewise, we were unable to detect either STAT3 homodimers or STAT1/3 lar to ours, it was shown that HGF-mediated tubulogenesis was STAT3 dependent (Boccaccio et al., 1998) . heterodimers in nuclear extracts of PKD1-expressing cells by EMSA ( Figure 3C ). We attribute this negative Therefore, we tested whether polycystin-1 expression might also result in activation of STAT3 using a luciferase result to the relatively modest level of activation and the typically transient nature of STAT3 phosphorylation reporter assay in HepG2 cells (whose endogenous STAT3 levels are relatively high). We cotransfected (Bromberg et al., 1998) . empty vector, PKD1-F, or R4227X-F with the reporter construct pSP72JunB-Luc (Matsumura et al., 1999) and Polycystin-1 Physically Interacts with JAK2 but Not JAK1 or Tyk2 found that only PKD1-F induced a significant increase (6-fold) of relative luciferase activity under these condiWe next sought to determine the mechanism by which polycystin-1 induces the phosphorylation of STAT1. In tions ( Figure 3D ). Next, we compared the relative lucifer- some growth factor-and cytokine-dependent prophorylated before they can activate STATs. We therefore tested whether any of the JAK2 bound to full-length or cesses, STATs are directly phosphorylated by the receptor tyrosine kinase itself (ie. EGFR; Darnell, 1997). Polymutant polycystin-1 was phosphorylated. We coexpressed HA-JAK2 with PKD1-F or R4227X-F, immunocystin-1 lacks a kinase domain and is unable to activate STAT1 directly by this mechanism. The majority of nonkiprecipitated the complex, and probed for JAK2 activation using ␣-phosphotyrosine antibodies. As shown in nase cytokine receptors that signal through STATs induce STAT phosphorylation through activation of a Figures 5A and 5C, phospho-JAK2 was found associated only with PKD1-F. These studies suggest that polymember of the Janus kinase family of tyrosine kinases (JAKs; Ihle, 1996). Of the four known members of the cystin-1 induces STAT1 activation by direct association and activation of JAK2. JAK family (JAK1-3 and Tyk2), all but JAK3 are widely expressed and thus could serve as potential partners of polycystin-1. We therefore tested whether any of the Polycystin-1 Requires Polycystin-2 for Activation of JAK2 ubiquitously expressed JAKs could physically associate with polycystin-1 in cultured cells. For JAK1 and JAK2, The identical phenotypes that result from mutation of PKD1 or PKD2 suggest that their gene products are we cotransfected expression constructs of each with PKD1-F, R4227X-F, or empty vector and tested for in likely to regulate a common signaling pathway (Qian et al., 1997). As noted in the Introduction, the cytoplasmic vivo association using an immunoprecipitation assay. Both PKD1-F and R4227X-F consistently coprecipitated carboxyl termini of their respective gene products associate via interactions between their respective coiledwith HA-JAK2 regardless of whether we used ␣-Flagcoupled agarose beads (M2-beads) or ␣-HA antibodies coil domains (Qian et al., 1997; Tsiokas et al., 1997). Mutations, such as the one used in the current study to perform the immunoprecipitation ( Figure 5A ). In contrast, neither protein was found complexed with JAK1 (R4227X) that altered the coiled-coil domain of either protein, were found to greatly decrease interactions beunder identical conditions ( Figure 5B ). We next tested whether polycystin-1 was able to associate with endogtween the two proteins (Hanaoka et al., 2000) . The observation that R4227X-F was able to bind but not activate enous JAKs. We transfected PKD1-F into Hek293 cells, isolated polycystin-1 using M2-beads, and probed for JAK2 prompted us to consider whether the activation of the JAK/STAT pathway by polycystin-1 required poly-JAK2 using ␣-JAK antiserum ( Figure 5C) . In parallel, we tested for JAK1 and Tyk2 binding using antiserum cystin-2. One piece of evidence arguing against this hypothesis specific for each. Although each of the JAKs was found expressed at approximately equal levels in Hek293 cells was the observation that we had found JAK/STAT activation in the absence of exogenous PKD2 expression. (data not shown), only JAK2 coprecipitated with PKD1-F ( Figure 5C ).
These results suggested either that PKD2 was not required for this property of polycystin-1 or that endogeAs noted above, Janus kinases must become phos- Given that all of our studies had been performed using a cell culture overexpression system, we sought to deof these cell lines. We subsequently identified a human lymphoblastoid cell line, CB33 (Shim et al., 1998) , that termine whether PKD1 also regulated this pathway in vivo. We focused our search on the later stages of emhad no detectable expression of polycystin-2 and used this to test the hypothesis ( Figure 6A ). PKD1-F, exbryonic development, since it has been previously shown that p21 waf is induced in differentiating tissues in pressed in the absence of PKD2, was able to bind to HA-JAK2 but could not induce its phosphorylation nor a p53-independent manner (Parker et al., 1995). The E14.5-E15.5 interval was targeted for analysis, since this induce upregulation of p21 waf ( Figure 6B ). Coexpression of PKD1-F with PKD2, however, resulted in both HAis the stage when renal cysts are first observed and the last for which viable homozygous null animals can be JAK2 phosphorylation and induction of p21 waf1 . Control studies performed using R4227X, Myc-R742X (a mutant reliably obtained. In pilot studies of wild-type (Pkd1 ϩ/ϩ ) and Pkd1 ϩ/Ϫ heterozygotes (n ϭ 5 for E14.5, n ϭ 3 for form of polycystin-2 incapable of interacting with polycystin-1; Hanaoka et al., 2000), and empty vector E15.5) and Pkd1 Ϫ/Ϫ null embryos (n ϭ 2 for each stage) at E14.5 and E15.5, we found that the level of p21 waf1 showed that these were specific effects of polycystin-1. Finally, we tested whether polycystin-2 was itself cawas relatively low at E14.5 in both sets of animals and then markedly higher at E15.5 in the normals (data not pable of binding JAK2 and thereby able to promote JAK2 transphosphorylation when polycystin-1 and -2 shown). In contrast, the level of p21 waf1 remained low in the homozygous animals at E15.5. We then focused our coassembled at the plasma membrane. We coexpressed HA-JAK2 with PKD2 in CB33 cells and tested studies on E15.5 and expanded the size of each set to include a total of 7 Pkd1
Ϫ/Ϫ and 18 Pkd1 ϩ/ϩ and Pkd1 ϩ/Ϫ for interaction using an immunoprecipitation assay. The proteins failed to coprecipitate in the absence of polyanimals from 5 litters. All studies were performed and interpreted in a blinded fashion, and representative recystin-1 (data not shown). Taken together, these results suggest that polycystin-2 is not necessary for the bindsults are presented in Figure 7A . Identical results were obtained: all null animals had much lower levels of p21 waf ing of JAK2 to polycystin-1, but is essential for its activation and the subsequent induction of p21 waf1 . than normal littermates. All blots were reprobed after stripping with antibodies for ␤-actin to verify equal loadwas absent and p21 waf1 staining was significantly reduced in these same tissues in Pkd1 null embryos. ing in each lane ( Figure 7B) .
We reasoned that if the normal upregulation of p21 waf1 that was observed at E15.5 was regulated at least in Discussion part by polycystin-1, then it should occur via activation of STAT1. Using the same set of samples tested for Studies of murine and human cystic tissues and cells suggest that altered regulation of renal tubular epithelial p21 waf1 expression, we assayed for pY701-STAT1 with epitope-specific antiserum. As before, all studies were cell growth and a block in terminal differentiation are key factors in the pathogenesis of ADPKD. Our in vitro performed in a blinded fashion. Representative results are presented in Figure 7C . pY701-STAT1 was present model of PKD1-induced tubulogenesis recently provided evidence that polycystin-1 might have a direct in all of the Pkd1 ϩ/ϩ and Pkd1 ϩ/Ϫ samples (n ϭ 14) and greatly reduced in each of the 5 Pkd1 Ϫ/Ϫ animals. We role in the regulation of these properties (Boletta et al., 2000). The present study describes a complete signaling excluded differences in total STAT1 expression by standard immunoblot studies as a trivial explanation for pathway by which polycystin-1 directly mediates some of these effects. We have shown that overexpression of these findings ( Figure 7D ). It is also important to note that all E15.5 nulls used in this study were viable, as PKD1 transmits its growth inhibitory signals from the cell surface to the nucleus via direct activation of the indicated by both standard clinical assessments and a battery of 10 biochemical markers that cover a range JAK-STAT pathway. Our data suggest that increased expression of p21 waf1 is primarily responsible for mediatof cellular stress response pathways and signaling systems (See Supplemental Data at http://www.cell.com/ ing the growth-suppressing effects of PKD1 in our experimental systems. These results are consistent with cgi/content/full/109/2/157/DC1). The observation that a total of 12 proteins had essentially identical levels of previous reports that have shown that sustained activation of STAT1 can lead to growth inhibition (Bromberg expression in the nulls versus normals/heterozygotes strongly argues against our findings being nonspecific et al., 1998). We also found that PKD1 is likely to signal through this pathway in vivo during fetal development. phenomena.
In a final set of experiments, we sought to relate the Murine embryos that lack Pkd1 have greatly reduced levels of STAT1 activation and p21 waf1 induction. These activation of STAT1 directly to polycystin-1 function. We reasoned that if the latter molecule is in fact responsible data suggest that PKD1 may be an important regulator of the normal developmental pattern of p21 waf1 exfor the upregulation of p21 is a combination of germline  caccio et al., 1998) . Interestingly, the earlier study had and acquired inactivation) are the net effects that result pathway by polycystin-1 occurred in the apparent absence of any exogenous factors (See Supplemental Data from dysregulation of multiple pathways. We believe our data strongly suggest that the JAK/STAT pathway is at http://www.cell.com/cgi/content/full/109/2/157/DC1). One possibility is that the PKD1 ϩ cells are functioning one of them.
While the PKD1-mediated activation of JAK-STAT sigin an autocrine manner, releasing a soluble factor in too low a concentration to be effective in conditioned naling follows the general schema described for this system, there are two unique aspects worth emphasizmedium. An alternative explanation is that the relatively high level of expression of polycystin-1 that was achieved ing. Most previously described examples of STAT activation by Janus kinases have required exogenous cyto-(compared to endogenous levels) was itself sufficient to induce receptor dimerization and activation, as has kines or growth factors for induction . One notable feature of our study is that activation of this been reported for receptor tyrosine and Janus kinases (Rui et al., 1997) . A final possibility is that the mechanism JAK-STAT signaling systems might also require a ubiqof activation of JAK2 by polycystin-1 differs from the uitously expressed cofactor for their proper function. conventional one.
Finally, the data presented in this study provide a The second novel aspect of the PKD1-regulated sysmechanistic explanation for how mutations of either tem is that it requires polycystin-2, a probable channel PKD1 or PKD2 
